Activist Ancora Wins Two Board Seats at Elanco Animal Health

April 1, 2024, 11:23 AM UTC

Elanco Animal Health Inc. has reached a settlement with Ancora Holdings Group LLC, allowing it to avoid a proxy fight with the activist investor.

Greenfield, Indiana-based Elanco has appointed Ancora nominees Craig Wallace and Kathy Turner as independent directors on its board, it said in a statement Monday that confirmed an earlier Bloomberg News report. Wallace and Turner will also join the Elanco board’s finance, strategy and oversight committee.

Led by Chief Executive Officer Jeff Simmons, Elanco provides products and services to prevent and treat disease in farm animals and pets. Shares in the company have risen ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.